#Novo #obesity #patentprotection #Wegovy #weightloss #Ozempic #diabetes #CagriSema #Foundayo #Haematology #haemophiliaA #Frehemgo #sicklecelldisease #PNH #blooddisorders #endocrinedisorders #liverdiseases #cardiovasculardisease #consumerRx

#Novo has moved a step closer to #EU approval of its long-acting #haemophiliaA therapy, #Frehemgo, after it was backed by the #EMA's human medicines committee.

pharmaphorum.com/news/chmp-ba...